RSV Vaccine Market Growth Prospects, Developments Plans, Future Insights and Trends Analysis Till 2035 The RSV vaccines landscape has transformed significantly since the approval of three RSV vaccines, namely Arexvy, Abrysvo and mRESVIA, since 2023. Ever since then, with the application of more advanced platforms to develop innovative vaccines, the life expectancy of patients with RSV diseases has risen remarkably. The majority (46%) of the developers were established during the period post-2010. Moreover, there has been an increase in the number of developers entering the RSV vaccine domain over the past decades, reflecting a stable and enticing industry for the new entrants. Examples of developers established post-2020 include (in reverse chronological order, established post-2019) RNApeak (2021), RVAC Medicines (2021), Starna Therapeutics (2021), Vaxmed (2020), Vernagen (2021) and RNAImmune (2020). It is worth highlighting that around 70 RSV vaccines are under different stages of development for patients suffering with respiratory syncytial virus infections. In fact, over 60% of the RSV vaccines are currently being evaluated in clinical trials to assess the safety and efficacy of these vaccines against RSV diseases. Over 35% of the RSV vaccines are a type of live attenuated vaccines, owing to the fact that live attenuated vaccines contain a live pathogen and the immune system reacts very well to these vaccines, resulting in a robust and long-lasting immune response. Further, close to 30% of the vaccines are subunit / viral-like-particle vaccines, which only contain inactive fragments of the pathogen and not the whole organism, thus reducing the chances of cross infections. Notable examples of live attenuated vaccines include (in alphabetical order, intramuscular vaccines) ChAdV155-RSV (GlaxoSmithKline), KD-409 (KM Biologics), RSV MEDI ΔM2-2 (National Institute of Allergy and Infectious Diseases) and SP0125 (Sanofi). Patent analysis: protecting intellectual property generated within RSV vaccines market- The majority (22.4%) of the patents were published in 2022, followed by patents published in 2024 (22.1%). This decrease in the number of patents published in 2023 is indicative of the growing preference for alternative RSV treatments such as monoclonal antibodies. In addition to this, majority (51%) of the patents were filed in North America, followed by Europe (16%). This is an indicative of robust patent activity for RSV vaccines in North America, owing to the recent approvals of several RSV vaccines in the respective region. However, the continuous expansion of RSV vaccine market is anticipated to drive patent filings as companies strive to differentiate their product portfolio to meet healthcare needs. Clinical trial analysis – evaluating the overall potential of RSV vaccines market- Most of the clinical trials assessing the safety and efficacy of these RSV vaccines in human beings, are in phase I (38%). This can be attributed to the fact that the application of RSV vaccines has shown a significant prevention of RSV and related complications among vulnerable patient groups. Owing to which, an upsurge has been witnessed in the R&D activity in this domain, and a large number of novel vaccine candidates have been identified that are being currently evaluated in the early phases of clinical trials. Additionally, it is worth highlighting that 31% of the clinical trials evaluating RSV vaccines are phase III studies, indicating that in the coming years more targeted drugs are likely to enter the RSV vaccine market. To view more details on this report, click on the link https://www.rootsanalysis.com/reports/rsv-vaccine-market.html About Roots Analysis Roots Analysis is a global research and consulting powerhouse specializing in Healthcare, Pharmaceutical, Biotech, Semiconductors, Chemicals and ICT industry. With over a decade of experience, they’ve supported more than 750 clients — spanning Fortune 500 companies, innovative startups, academic institutions, VCs, and strategic investors. Why Use Roots Analysis in era of Artificial Intelligence? 1. Tailored Insights 2. Robust Methodology 3. Smart Decisions Made Easy By combining world-class domain expertise, careful data gathering, and dialogue with senior industry experts, Roots Analysis ensures their deliveries are trustworthy, actionable, and aligned with strategic priorities. The value proposition generated on insights generated by Roots Analysis team is unparalleled in the market research industry. Services Offered: 1. Consulting Services (custom insights supporting strategic and tactical requirements, off-the-shelf ready to consume work) Roots Analysis offers bespoke consulting services tailored to the unique needs of clients in the life sciences and healthcare sectors. They specialize in market assessments, tracking industry trends, dynamics, and competitive positioning. These insights help companies fine-tune their product strategies and market-entry plans. Roots Analysis also delivers expert guidance on partnerships, licensing, and investment opportunities. Their strategic support extends to KOL identification, publication analysis, and regulatory intelligence, making them a valuable partner in business growth and innovation. 2. Subscription Services (bundled services supporting multiple topics and domains for a firm) With their subscription plans, Roots Analysis provides seamless access to a vast library of market intelligence reports. Subscribers enjoy unlimited downloads in multiple formats. The service includes on-demand research support—allowing clients to request tailored insights and initiate custom research topics. This ensures that emerging needs are met quickly and effectively. Each subscription comes with a dedicated account manager and direct access to analysts. Flexible billing options and tiered plans make this service suitable for organizations of all sizes seeking continuous, reliable insights. Contact Details for Roots Analysis Chief Executive: Gaurav Chaudhary Email: Gaurav.chaudhary@rootsanalysis.com Website: https://www.rootsanalysis.com/ Browse for more related reports https://pad.ifcat.org/s/kpifLxBe1 https://gitlab.cranecloud.io/johnwick5911/roots/-/issues/1 https://lospromotores.net/author/johnwick89/ https://www.baytalfann.com/profile/km306515890794/profile https://openprofile.dev/profile/johnwick90 https://demo.playtubescript.com/@johnwick99?page=about https://classmill.com/mkhanna https://glif.app/@M-6932 https://frenchdistrict.com/annonces/author/johnwick90/ https://www.ascecuba.org/profile/km306515841060/profile https://paizo.com/people/john993#newPost https://www.wearecora.org/profile/km306515892403/profile https://git.tbaer.de/johnwick90/Roots/issues/1 https://api.pushcrew.com/discuss/68be9b4b05b7ffe44113df59 https://sailorslife.in/question/probiotic-market-size-share-growth-factors-competitive-landscape-with-regional-forecast-to-2035/ https://www.callupcontact.com/b/businessprofile/nutrigenomics_market/9750313 https://www.halaltrip.com/user/profile/249273/jhanvi99/ https://londonchinese.com/home.php?mod=space&uid=593042&do=profile https://slideslive.com/spwz0dhyfnwo?tab=about https://www.weddingbee.com/members/jhanvikukreja416/ https://kai-you.net/u/jhanvi66 https://www.slideshare.net/jhanvikukreja416 https://cuchichi.es/author/jhanvi816/ https://www.scribd.com/user/855073394/jhanvikukreja416 https://www.goodreads.com/user/show/192672296-jhanvi-kukreja https://gravatar.com/jhanvikukreja416 https://soundcloud.com/jhanvi-kukreja-395028342 https://www.ted.com/profiles/49685180 https://www.tripadvisor.com/Profile/832jhanvik https://www.spreaker.com/podcast/nutrigenomics-market--6701804 https://pbase.com/chris890/inbox https://www.smitefire.com/profile/jhanvi81-222792?profilepage https://memo.cash/profile/1N78Ky4nxCasWxPvxaRXa3apNobKVTvaZx https://www.asklent.com/user/jhanvi99#gsc.tab=0 https://www.gog.com/u/jhanvikukreja416_7

Lung diseases such as pulmonary fibrosis, asthma, chronic obstructive pulmonary disease (COPD), etc., reduce the breathing capacity, making daily functions challenging. These disorders cause irreversible damage to the lungs and substantially decline the quality of life. The present medications only offer temporary relief by reducing inflammation and airway constriction. However, they are unable to repair the damage. However, Stem Cell treatment for lung disease has shown potential in damage repair and improving breathing capacity. Stem cells combat inflammation, regenerate tissue, and alleviate fibrosis to improve lung structure and function. The clinical studies have demonstrated improved lung function and breathing capacity while reducing disease progression. The translation of this treatment from bench to bedside still requires time. Large-scale clinical trials and long-term safety studies can accurately establish the effects of the treatment. Further optimization of the treatment protocol will soon make the stem cell treatment for COPD available in hospital settings. Read more-https://shorturl.at/7TtF1 #StemCellTherapy #LungDiseaseTreatment #COPDRecovery #PulmonaryHealth

The MSA treatment landscape is evolving with increased research into disease-modifying therapies targeting underlying pathology. Rising diagnostic rates and orphan drug development incentives are accelerating market growth. Biotechnology leaders including Biohaven Pharmaceuticals, Theravance Biopharma, and Modag GmbH are advancing innovative candidates addressing α-synuclein aggregation and neuroprotection in clinical trials. Access Detailed Market Forecast: https://www.delveinsight.com/infographics/multiple-system-atrophy-msa-market?utm_source=infographics&utm_medium=promotion&utm_campaign=kkpr

Artificial Intelligence (AI) in Healthcare Market Key Highlights and Future Opportunities Till 2035 Date of Publication: 2025-July-31 The Artificial Intelligence (AI) in Healthcare Market has been the subject of detailed research in a newly released report that presents a neutral and data-driven view of current and historical trends. The report serves as a reference point for businesses, analysts, and stakeholders seeking to understand key developments, market behavior, and regional segmentation within this domain. Included in the study is a summary of relevant market data, product coverage, technological updates, and emerging segment-level activity. The research report also highlights notable strategies being employed by companies operating in this space. Offered in both PDF and spreadsheet formats, the report is tailored for professionals seeking structured and accessible information on the Artificial Intelligence (AI) in Healthcare industry. The global artificial intelligence (AI) in healthcare market size, valued at USD 22.61 billion in 2024, is expected to reach USD 35.71 billion in 2025 and USD 765.12 billion by 2035, representing a higher CAGR of 35.9% during the forecast period. The report offers updated metrics and segment-wise insights to help users stay aligned with market direction and interpret available data effectively. Key Companies Profiled. This segmentation offers a clear breakdown of industry structure and allows for comparative assessment across products, use cases, and regions. The report also outlines key differences among various market categories while presenting an overview of performance based on volume and value indicators. Reference: https://www.rootsanalysis.com/reports/artificial-intelligence-ai-healthcare-market.html Key Market Players The report includes a detailed review of several leading companies in the Artificial Intelligence (AI) in Healthcare Market, such as Google, GE Healthcare, IBM, Intel, Itrex, IQVIA, Microsoft, Medtronic, Medidata, Merck, NVIDIA, Oracle. Each organization is presented with reference to product focus, operational regions, and recent corporate activity. Information includes company background, portfolio scope, revenue performance, and developments observed within the reporting period. This section provides context on the market positioning of each player and outlines relevant business strategies, including sales approaches, geographic focus, and product-level alignment. The intent is to deliver a factual and unbiased summary of how these firms operate within the current market structure. Geographical Insights The report presents regional segmentation based on accumulated revenue and distribution channels. Forecasted data and recorded activity are shared for North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. The analysis covers how each region contributes to the overall Artificial Intelligence (AI) in Healthcare Market share while maintaining consistency in measurement standards and data interpretation. Main Chapters in the Report: Part 01: Market Overview Part 02: Market Size, by regions Part 03: Market Revenue, by countries Part 04: Market Competition, by key players Part 05: Company Profiles Thank you for your interest in this research report. For more information or to receive a customized version based on your business needs, feel free to contact our team. We are here to assist with further insights and tailored data support. About Roots Analysis Roots Analysis is a global research and consulting powerhouse specializing in Healthcare, Pharmaceutical, Biotech, Semiconductors, Chemicals and ICT industry. With over a decade of experience, they’ve supported more than 750 clients — spanning Fortune 500 companies, innovative startups, academic institutions, VCs, and strategic investors. Their expertise covers a wide set of domains, including market sizing, pricing trends, regulatory outlooks, competitive landscapes, and opportunity mapping across geographies. Why Use Roots Analysis in era of Artificial Intelligence? Tailored Insights Robust Methodology Smart Decisions Made Easy By combining world-class domain expertise, careful data gathering, and dialogue with senior industry experts, Roots Analysis ensures their deliveries are trustworthy, actionable, and aligned with strategic priorities. The value proposition generated on insights generated by Roots Analysis team is unparalleled in the market research industry. Services Offered: Consulting Services (custom insights supporting strategic and tactical requirements, off-the-shelf ready to consume work) Roots Analysis offers bespoke consulting services tailored to the unique needs of clients in the life sciences and healthcare sectors. Their team conducts in-depth studies on drug pipelines, clinical trials, and therapeutic landscapes, helping clients make informed decisions. They specialize in market assessments, tracking industry trends, dynamics, and competitive positioning. These insights help companies fine-tune their product strategies and market-entry plans. Roots Analysis also delivers expert guidance on partnerships, licensing, and investment opportunities. Their strategic support extends to KOL identification, publication analysis, and regulatory intelligence, making them a valuable partner in business growth and innovation. Subscription Services (bundled services supporting multiple topics and domains for a firm) With their subscription plans, Roots Analysis provides seamless access to a vast library of market intelligence reports. Subscribers enjoy unlimited downloads in multiple formats, covering various sectors like pharma, biotech, and diagnostics. The service includes on-demand research support—allowing clients to request tailored insights and initiate custom research topics. This ensures that emerging needs are met quickly and effectively. Each subscription comes with a dedicated account manager and direct access to analysts. Flexible billing options and tiered plans make this service suitable for organizations of all sizes seeking continuous, reliable insights. Contact Details for Roots Analysis Chief Executive: Gaurav Chaudhary Email: Gaurav.chaudhary@rootsanalysis.com Website: https://www.rootsanalysis.com/